Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation.

Abstract excerpt

BACKGROUND: Fabry disease is a lysosomal storage disorder with an incidence of 1:1600 for the late-onset IVS4+919G>A cardiac variant mutation in Taiwan. Signs and symptoms of this cardiac variant include left ventricular hypertrophy, mitral insufficiency and/or arrhythmias. The search for biomarkers that might predict the clinical outcomes and guide treatment options is important. We thus investigated...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age Factors
• Share to Fabry Disease